Correction: Alqahtani et al. The Development of Risperidone-Loaded Microfibers via Centrifugal Spinning to Enhance the Palatability of a Potential Drug for Autistic Children. Pharmaceutics 2025, 17, 1403

Key Points

• To create a more palatable form of risperidone for use in children with autism.
• Developed risperidone-loaded microfibers through centrifugal spinning.
• Tested the physical properties of the microfibers for drug delivery.
• Evaluated the palatability of the new formulation in a relevant setting.
• The microfibers demonstrated improved drug release compared to traditional forms.
• Feedback on palatability was positive, indicating acceptance in children.
• Enhanced physical properties were noted in the developed microfibers.